XML 17 R5.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Beginning balance, value at Dec. 31, 2020 $ (124,001) $ 6 $ 754,938 $ (878,945)
Beginning balance, shares at Dec. 31, 2020   5,996,000    
Shares issued for sale of common stock, net of cost 150,899 $ 2 150,897  
Shares issued for sale of common stock, net of cost, shares   1,857,000    
Shares issued for exercise of warrants and options, net of cashless exercises 50   50  
Shares issued for exercise of warrants and options, net of cashless exercises (in shares)   10,000    
Shares issued for vested restricted stock units (in shares)   1,000    
Share-based compensation 2,957   2,957  
Net loss (39,383)     (39,383)
Ending balance, value at Mar. 31, 2021 (9,478) $ 8 908,842 (918,328)
Ending balance, shares at Mar. 31, 2021   7,864,000    
Beginning balance, value at Dec. 31, 2021 $ (93,621) $ 9 957,730 (1,051,360)
Beginning balance, shares at Dec. 31, 2021 8,598,000 8,598,000    
Shares issued for vested restricted stock units (in shares)   71,000    
Share-based compensation $ 2,062   2,062  
Net loss (49,021)     (49,021)
Ending balance, value at Mar. 31, 2022 $ (140,580) $ 9 $ 959,792 $ (1,100,381)
Ending balance, shares at Mar. 31, 2022 8,669,000 8,669,000